rs766309374
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032634.4(PIGO):c.1363A>G(p.Thr455Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,461,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. T455T) has been classified as Uncertain significance.
Frequency
Consequence
NM_032634.4 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hyperphosphatasia with intellectual disability syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), PanelApp Australia
- hyperphosphatasia-intellectual disability syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032634.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGO | NM_032634.4 | MANE Select | c.1363A>G | p.Thr455Ala | missense | Exon 7 of 11 | NP_116023.2 | ||
| PIGO | NM_001201484.2 | c.1344+19A>G | intron | N/A | NP_001188413.1 | ||||
| PIGO | NM_152850.4 | c.1344+19A>G | intron | N/A | NP_690577.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGO | ENST00000378617.4 | TSL:1 MANE Select | c.1363A>G | p.Thr455Ala | missense | Exon 7 of 11 | ENSP00000367880.3 | ||
| PIGO | ENST00000298004.9 | TSL:1 | c.1344+19A>G | intron | N/A | ENSP00000298004.5 | |||
| PIGO | ENST00000465745.6 | TSL:2 | n.2364A>G | non_coding_transcript_exon | Exon 3 of 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250806 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461822Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 727204 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hyperphosphatasia with intellectual disability syndrome 2 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with PIGO-related disease. This variant is present in population databases (rs766309374, ExAC 0.002%). This sequence change replaces threonine with alanine at codon 455 of the PIGO protein (p.Thr455Ala). The threonine residue is weakly conserved and there is a small physicochemical difference between threonine and alanine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at